A novel diagnostic approach to patients with myoclonus

Myoclonus is a hyperkinetic movement disorder characterized by brief, involuntary muscular jerks. Recognition of myoclonus and determination of the underlying aetiology remains challenging given that both acquired and genetically determined disorders have varied manifestations. The diagnostic work-up in myoclonus is often time-consuming and costly, and a definitive diagnosis is reached in only a minority of patients. On the basis of a systematic literature review up to June 2015, we propose a novel diagnostic eight-step algorithm to help clinicians accurately, efficiently and cost-effectively diagnose myoclonus. The large number of genes implicated in myoclonus and the wide clinical variation of these genetic disorders emphasize the need for novel diagnostic techniques. Therefore, and for the first time, we incorporate next-generation sequencing (NGS) in a diagnostic algorithm for myoclonus. The initial step of the algorithm is to confirm whether the movement disorder phenotype is consistent with, myoclonus, and to define its anatomical subtype. The next steps are aimed at identification of both treatable acquired causes and those genetic causes of myoclonus that require a diagnostic approach other than NGS. Finally, other genetic diseases that could cause myoclonus can be investigated simultaneously by NGS techniques. To facilitate NGS diagnostics, we provide a comprehensive list of genes associated with myoclonus.

[1]  J. Lance,et al.  Negative myoclonus in posthypoxic patients: Historical note , 2001, Movement disorders : official journal of the Movement Disorder Society.

[2]  A. Federico,et al.  Cerebrotendinous Xanthomatosis , 2003, Journal of child neurology.

[3]  J. Valk,et al.  Alexander disease: diagnosis with MR imaging. , 2001, AJNR. American journal of neuroradiology.

[4]  A. Vincent,et al.  Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses , 2013, European Neurology.

[5]  G. Consales,et al.  Propriospinal myoclonus following intrathecal bupivacaine in hip surgery: a case report. , 2010, Minerva anestesiologica.

[6]  J. Valls-Solé,et al.  Postural and action myoclonus in patients with parkinsonian type multiple system atrophy , 2000, Movement disorders : official journal of the Movement Disorder Society.

[7]  J. Montastruc,et al.  Drug-induced myoclonus: a French pharmacovigilance database study , 2006, Neurophysiologie Clinique/Clinical Neurophysiology.

[8]  K. Lyseng-Williamson Miglustat: A Review of Its Use in Niemann-Pick Disease Type C , 2013, Drugs.

[9]  C. Tassinari,et al.  Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management , 2006, Neurophysiologie Clinique/Clinical Neurophysiology.

[10]  F. Zara,et al.  Expanding sialidosis spectrum by genome-wide screening , 2014, Neurology.

[11]  Eleonora Aronica,et al.  Decreased cortical inhibition and yet cerebellar pathology in ‘familial cortical myoclonic tremor with epilepsy’ , 2007, Movement disorders : official journal of the Movement Disorder Society.

[12]  A. Gregory,et al.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation , 2008, Journal of Medical Genetics.

[13]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[14]  J. Rothwell,et al.  The role of the cerebellum in the pathogenesis of cortical myoclonus , 2014, Movement disorders : official journal of the Movement Disorder Society.

[15]  M. Vidailhet,et al.  Myoclonus or tremor in orthostatism: An under‐recognized cause of unsteadiness in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  J. Matsumoto,et al.  Orthostatic myoclonus , 2007, Neurology.

[17]  M. Hallett,et al.  The nosology and pathophysiology of myoclonus , 1981 .

[18]  F. Sedel,et al.  Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. , 2012, Molecular genetics and metabolism.

[19]  M. Nogués Spontaneous electromyographic activity in spinal cord lesions , 2002, Muscle & nerve. Supplement.

[20]  M. Borg Symptomatic myoclonus , 2006, Neurophysiologie Clinique/Clinical Neurophysiology.

[21]  S. Gallati,et al.  Targeted next generation sequencing as a diagnostic tool in epileptic disorders , 2012, Epilepsia.

[22]  Carla Cordivari,et al.  Myoclonic disorders: a practical approach for diagnosis and treatment , 2011, Therapeutic advances in neurological disorders.

[23]  D. Pareyson,et al.  Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. , 2008, Brain : a journal of neurology.

[24]  B. Calancie,et al.  Spinal Myoclonus After Spinal Cord Injury , 2006, The journal of spinal cord medicine.

[25]  E. Frechette,et al.  Extreme delta brush , 2012, Neurology.

[26]  M. Tijssen,et al.  Source (or Part of the following Source): Type Article Title Axial Jerks: a Clinical Spectrum Ranging from Propriospinal to Psychogenic Myoclonus Author(s) Axial Jerks: a Clinical Spectrum Ranging from Propriospinal to Psychogenic Myoclonus , 2022 .

[27]  C. Adler,et al.  Myoclonus in Lewy body disorders. , 2002, Advances in neurology.

[28]  G. Arunodaya,et al.  Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades , 2007, Medicine.

[29]  V. Lal,et al.  A test for Creutzfeldt-Jakob disease using nasal brushings. , 2014, The New England journal of medicine.

[30]  K. Engelstad,et al.  Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) , 2013, Current Neurology and Neuroscience Reports.

[31]  E. Broussolle,et al.  Atypical propriospinal myoclonus with possible relationship to alpha interferon therapy. , 2003, Movement disorders : official journal of the Movement Disorder Society.

[32]  V. Loreto,et al.  Spinal myoclonus following herpes zoster radiculitis , 2007, Neurology.

[33]  F. Manes,et al.  Involuntary movements and abnormal spontaneous EMG activity in syringomyelia and syringobulbia , 1999, Neurology.

[34]  P. Wen,et al.  Paraneoplastic opsoclonus‐myoclonus associated with anti‐Hu antibody , 1994, Neurology.

[35]  Anand I. Rughani,et al.  Surgical treatment of myoclonus dystonia syndrome , 2013, Movement disorders : official journal of the Movement Disorder Society.

[36]  Hiroshi Shibasaki,et al.  Electrophysiological studies of myoclonus. , 2005, Muscle & nerve.

[37]  R. Schiffmann,et al.  Alexander Disease , 2019, Definitions.

[38]  H. Brisse,et al.  Opsoclonus-myoclonus in children associated or not with neuroblastoma. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[39]  H. Shibasaki,et al.  Electroencephalographic studies of myoclonus. Myoclonus-related cortical spikes and high amplitude somatosensory evoked potentials , 1978 .

[40]  E. Broussolle,et al.  Atypical propriospinal myoclonus with possible relationship to α interferon therapy , 2003 .

[41]  D. Zafeiriou,et al.  Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. , 2010, Brain : a journal of neurology.

[42]  M. T. Pellecchia,et al.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration , 2005, Neurology.

[43]  R. D. de Haan,et al.  The eye of the beholder: inter-rater agreement among experts on psychogenic jerky movement disorders , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  A. Kastrup,et al.  Progressive encephalomyelitis with rigidity and myoclonus , 2014, Neurology.

[45]  S. Tenembaum,et al.  Negative motor phenomena in generalized epilepsies. A study of atonic seizures. , 1995, Advances in neurology.

[46]  M. Gordon Toxin and drug-induced myoclonus. , 2002, Advances in neurology.

[47]  B. Post,et al.  Propriospinal myoclonus after treatment with ciprofloxacin , 2004, Movement disorders : official journal of the Movement Disorder Society.

[48]  H. Shibasaki,et al.  Electroencephalographic studies myoclonus. , 1978, Brain : a journal of neurology.

[49]  R. Sinke,et al.  Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges , 2015, Expert review of molecular diagnostics.

[50]  Patrick F. Chinnery,et al.  Exome sequencing: how to understand it , 2013, Practical Neurology.

[51]  C. Adler,et al.  Electrophysiology of the myoclonus in dementia with Lewy bodies , 2003, Neurology.

[52]  J. Caviness,et al.  Myoclonus: current concepts and recent advances , 2004, The Lancet Neurology.

[53]  M. Tijssen,et al.  Management of patients with myoclonus: available therapies and the need for an evidence-based approach , 2010, The Lancet Neurology.

[54]  M. Zeviani,et al.  Myoclonus in mitochondrial disorders , 2014, Movement disorders : official journal of the Movement Disorder Society.

[55]  C. Adler,et al.  Small‐Amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations , 2002, Movement disorders : official journal of the Movement Disorder Society.

[56]  D. Kömpf,et al.  Peripheral myoclonus due to spinal root lesion , 1997, Muscle & nerve.

[57]  Jean-Pierre Lin,et al.  A field guide to current advances in paediatric movement disorders. , 2015, Current opinion in neurology.

[58]  G. Sutton,et al.  Focal reflex myoclonus 1 , 1974, Journal of neurology, neurosurgery, and psychiatry.

[59]  C. Marsden,et al.  Definition and classification of myoclonus. , 1986, Advances in neurology.

[60]  J. R. Rosenberg,et al.  Coherent cortical and muscle discharge in cortical myoclonus. , 1999, Brain : a journal of neurology.

[61]  D. Gruber,et al.  Pallidal and thalamic deep brain stimulation in myoclonus‐dystonia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[62]  S. Dimauro,et al.  Clinical features and genetics of myoclonic epilepsy with ragged red fibers. , 2002, Advances in neurology.

[63]  R. Reading,et al.  Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .

[64]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[65]  S. Fahn,et al.  The clinical spectrum of posthypoxic myoclonus , 2000, Movement disorders : official journal of the Movement Disorder Society.

[66]  Xuebing Cao,et al.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management , 2014, Orphanet Journal of Rare Diseases.

[67]  F. Baas,et al.  SGCE isoform characterization and expression in human brain: implications for myoclonus–dystonia pathogenesis? , 2011, European Journal of Human Genetics.

[68]  M. Short,et al.  Brachial plexus myoclonus. , 1985, Journal of Neurology Neurosurgery & Psychiatry.

[69]  S. Kaler,et al.  Wilson's disease and other neurological copper disorders , 2015, The Lancet Neurology.

[70]  S. Tobimatsu,et al.  Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. , 1985, Brain : a journal of neurology.

[71]  M. Edwards,et al.  Propriospinal myoclonus , 2014, Neurology.

[72]  A. Spiro Minipolymyoclonus: A neglected sign in childhood spinal muscular atrophy , 1970 .

[73]  D. Maraganore,et al.  The incidence and prevalence of myoclonus in Olmsted County, Minnesota. , 1999, Mayo Clinic proceedings.

[74]  J. Hardy,et al.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[75]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[76]  M. Verbeek,et al.  Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. , 2013, JAMA neurology.